In Vitro Evaluation of Fosfomycin Combinations Against Metallo-β-Lactamase-Producing Klebsiella pneumoniae and Pseudomonas aeruginosa Clinical Isolates
Esther Wohlfarth, Aurélien Dinh, Georgia Vrioni, Dorota Żabicka, Mariano Bernardo, Carlo Tascini, Latifa Noussair, Christian Mayer, Ágnes Pál-Sonnevend · 2025
Read In Vitro Evaluation of Fosfomycin Combinations Against Metallo-β-Lactamase-Producing Klebsiella pneumoniae and Pseudomonas aeruginosa Clinical Isolates by Esther Wohlfarth, Aurélien Dinh, Georgia Vrioni, Dorota Żabicka, Mariano Bernardo, Carlo Tascini, Latifa Noussair, Christian Mayer, Ágnes Pál-Sonnevend (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729803.txt.
Description
Esther Wohlfarth and co-authors tested in 2025 whether an old antibiotic, fosfomycin, can rescue newer ones against bacteria armed with metallo enzymes that chew up most penicillin-family drugs. Forty-two resistant clinical isolates of two species faced fosfomycin paired with seven partners in checkerboard and time-kill tests.
Most pairings added up or synergized. The best couples differed by species: a modern protected cephalosporin for one, colistin for the other. In the strongest pairing, fosfomycin boosted its partner more than the reverse. Combinations also stopped the regrowth seen when drugs worked alone. The authors back fosfomycin pairs as rational therapy candidates for these hard infections. Clinical trials must now test what the dishes promise.
Catalog record
| CREATOR | Esther Wohlfarth, Aurélien Dinh, Georgia Vrioni, Dorota Żabicka, Mariano Bernardo, Carlo Tascini, Latifa Noussair, Christian Mayer, Ágnes Pál-Sonnevend |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |